References

Geriatric oncology: an overview of progresses and challenges

10.4143/crt.2010.42.2.61 · 2010 · External reference

Pharmacology of anticancer drugs in the elderly: tools for dose-adjustment

2008 · External reference

Superacidic generation of new antitumour agents

2000 · External reference

Vinflunine, a second generation novel Vinca Alkaloid with a distinctive pharmacological profile, now in clinical development and prospects for future mitotic blockers

10.2174/1381612013397456 · 2001 · External reference

Vinflunine (20′,20′-difluoro-3′,4′-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro

10.1023/a:1006022811895 · 1998 · External reference

Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunine

10.1124/mol.60.1.225 · 2001 · External reference

Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells

10.1097/00001813-199907000-00005 · 1999 · External reference

A comparison of thermodynamic parameters for vinorelbine- and vinflunine-induced tubulin self-association by sedimentation velocity

10.1016/s0026-895x(24)13258-0 · 1998 · External reference

A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen

10.1038/sj.bjc.6603118 · 2006 · External reference

Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract

10.1200/jco.2008.20.5534 · 2009 · External reference

Vinflunine

10.2165/11204970-000000000-00000 · 2010 · External reference

Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumours

10.1093/annonc/mdg174 · 2003 · External reference

Phase I study of IV vinflunine given on a weekly schedule in previously untreated patients with advanced solid tumours

2003 · External reference

Phase I study of vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks

10.1007/s10637-005-3902-0 · 2006 · External reference

Vinflunine metabolism and disposition in cancer patients

2002 · External reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

10.1002/ijc.25516 · 2010 · External reference

Pharmacology of anticancer drugs in the elderly population

10.2165/00003088-200342140-00003 · 2003 · External reference

Unresolved reference

External reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

10.1093/jnci/92.3.205 · 2000 · External reference

A simple and sensitive high-performance liquid chromatographic method for the determination of vinflunine and 4-O-deacetylvinflunine from human blood

10.1097/ftd.0b013e3181f6010c · 2010 · External reference

Influence of renal dysfunction on the pharmacokinetic of i.v. vinflunine: results of a phase I trial in cancer patients

2011 · External reference

Pharmacokinetics and drug metabolism in the elderly

10.1080/03602530902722679 · 2009 · External reference

Unresolved reference

2011 · External reference